![C45H56N7O9P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl- N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl) phosphoramidite] (ACI)](http://cdn.globalso.com/nvchem/style/global/img/demo/page_banner.jpg)
![C45H56N7O9P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl- N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl) phosphoramidite] (ACI) Featured Image](https://cdn.globalso.com/nvchem/C45H56N7O9P.png)
C45H56N7O9P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-methyl- N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl) phosphoramidite] (ACI)
Cas Subcriptio Number
150780-67-9
H303
| Key physica proprietatibus | Valor | Conditio |
| Pondus | 869,94 | - |
| Pka (praedicta) | 9.16 ± 0.20 | Most Acidic Temp: XXV ° C |
N#CCCOP(OC1C(OC(N2C= NC=3C(=O)N=C(NC(=O)C(C)C)NC32)C1OC)COC(C=4C=CC=CC4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)N(C( C)C)C(C)C
Isomeric smiles
C(OC[C@@H]1[C@@H](OP(N(C(C)C)C(C)C)OCCC#N)[C@@H](OC)[C@@H](O1)N2C3=C(N=C2)C(=O)N=C(NC(C(C)C)=O)N3)(C4=CC=C(OC) C = c4), (c5 = c (c) c = C5) C6 = CC = c6 c6
INCHI
Inchi = 1s / C45H56N7O9P / C1-28 (II) XLI (LIII) 49-44-48-40-37 (XLII (LIV) 50-44) 47-27-51 (XL) 43-39 (57-9) XXXVIII (61-62 (59-25-13-24
46)52(29(3)4)30(5)6)36(60-43)26-58-45(31-14-11-10-12-15-31,32-16-20-34(55-7)21-17-32)33-18-22-35(56-8)23-19-33/h10-12,14-23,27 -30,36,38-39,43h, 13,25-26h2,1-9h3 (H2,48,49,5,53,54) / T36-, 38-, 39-, 43-, LXII? / M1 / S1?
Key Inchi
Irrdhrzuoznwdj, mlldkzsosa, n
I aliud nomen huius substantiae
Guanosine, V '-O- [bis (IV-metoxyphen) Phenylmethyl] -2 '-O-methyl-N- (II-methyl, I-oxopropyl) -, III, - [II-cyanoethyl bis (I-methylethyl) phosphoramidite] (9ci)
Spectra praesto
XIII c NMR
Nmr hetero
Proprietatibus praesto
Biological
Proiectus
Lipinski
Structuram related
| Res | Valor | Conditio | Fons |
| Bioconcentration factor | CLXXXIII | PH I; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | MMMDCCCXC | PH II; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | (XXXV) D | PH III; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.08 x CV | PH IV; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.36 x CV | PH V; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.39 x CV | Ph VI; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.38 x CV | PH VII; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.24 x CV | PH VIII; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | (LXIII) DC | PH IX; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | (XI) CM | PH X; Temp: XXV ° C | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Conditio | Fons |
| Koc | CCXX | PH I; Temp: XXV ° C | (I) ACD |
| Koc | (IV) DCLXXX | PH II; Temp: XXV ° C | (I) ACD |
| Koc | (XLII) DC | PH III; Temp: XXV ° C | (I) ACD |
| Koc | 1.30 x CV | PH IV; Temp: XXV ° C | (I) ACD |
| Koc | 1.63 x CV | PH V; Temp: XXV ° C | (I) ACD |
| Koc | 1.67 x CV | Ph VI; Temp: XXV ° C | (I) ACD |
| Koc | 1.65 x CV | PH VII; Temp: XXV ° C | (I) ACD |
| Koc | 1.49 x CV | PH VIII; Temp: XXV ° C | (I) ACD |
| Res | Valor | Conditio | Fons |
| Koc | (LXXVI) CD | PH IX; Temp: XXV ° C | (I) ACD |
| Koc | (XIV) CC | PH X; Temp: XXV ° C | (I) ACD |
| logd | 4.19 | PH I; Temp: XXV ° C | (I) ACD |
| logd | 5.52 | PH II; Temp: XXV ° C | (I) ACD |
| logd | 6,48 | PH III; Temp: XXV ° C | (I) ACD |
| logd | 6,96 | PH IV; Temp: XXV ° C | (I) ACD |
| logd | 7.06 | PH V; Temp: XXV ° C | (I) ACD |
| logd | 7.07 | Ph VI; Temp: XXV ° C | (I) ACD |
| logd | 7.07 | PH VII; Temp: XXV ° C | (I) ACD |
| logd | 7.02 | PH VIII; Temp: XXV ° C | (I) ACD |
| logd | 6,73 | PH IX; Temp: XXV ° C | (I) ACD |
| logd | 6.00 | PH X; Temp: XXV ° C | (I) ACD |
| logp | 7.072 ± 0.721 | Temp: XXV ° C | (I) ACD |
| Missam intrinsecam solubility | X 10-4 G / l | Temp: XXV ° C | (I) ACD |
| Missam solubility | 0.096 g / l | PH I; Temp: XXV ° C | (I) ACD |
| Missam solubility | X 4.3 10-3 G / l | PH II; Temp: XXV ° C | (I) ACD |
| Missam solubility | 10-4 X 10-4 g / l | PH III; Temp: XXV ° C | (I) ACD |
| Missam solubility | 1.6 x 10-4 g / l | PH IV; Temp: XXV ° C | (I) ACD |
| Missam solubility | X 10-4 G / l | PH V; Temp: XXV ° C | (I) ACD |
| Missam solubility | X 10-4 G / l | Ph VI; Temp: XXV ° C | (I) ACD |
| Missam solubility | X 10-4 G / l | PH VII; Temp: XXV ° C | (I) ACD |
| Missam solubility | 10-4 10-4 G / l | PH VIII; Temp: XXV ° C | (I) ACD |
| Missam solubility | X 10-4 G / l | PH IX; Temp: XXV ° C | (I) ACD |
| Missam solubility | 10-3 10-3 g / l | PH X; Temp: XXV ° C | (I) ACD |
| Missam solubility | X 10-4 G / l | Unbuffered aqua PH 7.00; Temp: XXV ° C | (I) ACD |
| Molaris intrinsecam solubility | X 10-7 Mol / l | Temp: XXV ° C | (I) ACD |
| Molaris solubility | X 10-4 Mol / l | PH I; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 5.0 x 10-6 Mol / l | PH II; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 5.5 x 10-7 Mol / l | PH III; Temp: XXV ° C | (I) ACD |
| Molaris solubility | X 10-7 Mol / l | PH IV; Temp: XXV ° C | (I) ACD |
| Molaris solubility | X 10-7 Mol / l | PH V; Temp: XXV ° C | (I) ACD |
| Molaris solubility | X 10-7 Mol / l | Ph VI; Temp: XXV ° C | (I) ACD |
| Res | Valor | Conditio | Fons |
| Molaris solubility | X 10-7 Mol / l | PH VII; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1.6 x 10-7 Mol / l | PH VIII; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 10-7 Mol X 3.1 / l | PH IX; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1.6 x 10-6 Mol / l | PH X; Temp: XXV ° C | (I) ACD |
| Molaris solubility | X 10-7 Mol / l | Unbuffered aqua PH 7.00; Temp: XXV ° C | (I) ACD |
| Pondus | 869,94 | ||
| PKA | 9.16 ± 0.20 | Most Acidic Temp: XXV ° C | (I) ACD |
| PKA | 3.45 ± 0.70 | Maxime basic temp: XXV ° | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Conditio | Fons |
| Sponte Rotatable vincula | 19 | (I) ACD | |
| H acceptors | 16 | (I) ACD | |
| H donos | 2 | (I) ACD | |
| H donator / Acceptor Sum | 18 | (I) ACD | |
| logp | 7.072 ± 0.721 | Temp: XXV ° C | (I) ACD |
| Pondus | 869,94 |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
| Res | Valor | Source |
| Polar superficies regio | CXCIV A2 | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Spectra praesto
I h NMR
XIII c NMR
| Codex | Aleam dicitur | Fons |
| H303 | Sit noxia, si absorbuit | Peritus curated |
![C39H46FN4O8P Uridine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -deoxy-2′ – fluoro-, 3′ – [2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] (ACI)](https://cdn.globalso.com/nvchem/C39H46FN4O8P-Uridine-300x300.png)
![C21H21N3O6 Thymidine, α - [(I-Naphthalenylenylenyl) amino] - α -Oxo- (ACI)](https://cdn.globalso.com/nvchem/C21H21N3O6-Thymidine-300x300.png)
![CXVIII re36h44n2o8si uridine, 5'-o- [bis (IV-methoxyphen) Phenylmethyl] -2'-o - [(1,1- Dimethylethyl) Dimethylyl] - (9CI, ACI)](https://cdn.globalso.com/nvchem/118-Re36H44N2O8Si-Uridine-300x300.jpg)
![C13h13No5 1h-Pyrano [3,4-F] indolifine, 3,6,10 (4h) -trione, IV-ethyl-7,8-dihydro-4ci, aci) H319, H301](https://cdn.globalso.com/nvchem/C13H13NO5-1H-Pyrano-300x300.jpg)
![C47H60N7O10P Guanosine, 5′ -O- [bis(4-methoxyphenyl)phenylmethyl]-2′ -O-(2- methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 3′ – [2-cyanoethyl N,N-bis (1-methylethyl)phosphoramidite] (ACI)](https://cdn.globalso.com/nvchem/C47H60N7O10P-Guanosine-300x300.png)